Literature DB >> 1084801

The minimum protective level of antibodies in smallpox.

J K Sarkar, A C Mitra, M K Mukherjee.   

Abstract

Blood samples from 57 contacts of 6 smallpox cases were tested for haemagglutination-inhibiting (HI) and neutralizing antibodies. All 6 contacts who subsequently developed smallpox were unvaccinated and had neutralizing antibody titres of 10 or less. However, 6 unvaccinated contacts with similar antibody levels did not develop smallpox. None of the 41 vaccinated contacts, regardless of their antibody level, contracted the disease.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1084801      PMCID: PMC2366379     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  8 in total

1.  Virus and virus antigen in the blood of smallpox patients; their significance in early diagnosis and prognosis.

Authors:  A W DOWNIE; K MCCARTHY; A MACDONALD; F O MACCALLUM; A E MACRAE
Journal:  Lancet       Date:  1953-07-25       Impact factor: 79.321

2.  Virus excretion in smallpox. 1. Excretion in the throat, urine, and conjunctiva of patients.

Authors:  J K Sarkar; A C Mitra; M K Mukherjee; S K De; D G Mazumdar
Journal:  Bull World Health Organ       Date:  1973-05       Impact factor: 9.408

3.  Pattern of intrafamilial transmission of smallpox in Calcutta, India.

Authors:  M K Mukherjee; J K Sarkar; A C Mitra
Journal:  Bull World Health Organ       Date:  1974       Impact factor: 9.408

4.  [Collection of blood on filter paper disks for the purpose of serological studies].

Authors:  M Duca; G Vancea; D Buiuc; V Moroşanu; A Ivan
Journal:  Microbiol Parazitol Epidemiol (Bucur)       Date:  1968 Sep-Oct

5.  Antibody response in haemorrhagic smallpox.

Authors:  J K Sarkar; S N Chatterjee; A C Mitra; A Mondal
Journal:  Indian J Med Res       Date:  1967-11       Impact factor: 2.375

6.  A study of inapparent infection in smallpox.

Authors:  G G Heiner; N Fatima; R W Daniel; J L Cole; R L Anthony; F R McCrumb
Journal:  Am J Epidemiol       Date:  1971-09       Impact factor: 4.897

7.  Virus excretion in smallpox. 2. Excretion in the throats of household contacts.

Authors:  J K Sarkar; A C Mitra; M K Mukherjee; S K De
Journal:  Bull World Health Organ       Date:  1973-05       Impact factor: 9.408

8.  Virulence of variola virus isolated from smallpox cases of varying severity.

Authors:  J K Sarkar; A C Mitra
Journal:  Indian J Med Res       Date:  1967-01       Impact factor: 2.375

  8 in total
  36 in total

1.  Long-lived poxvirus immunity, robust CD4 help, and better persistence of CD4 than CD8 T cells.

Authors:  Rama Rao Amara; Pragati Nigam; Sunita Sharma; Jinyan Liu; Vanda Bostik
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

Review 2.  Correlates of protection induced by vaccination.

Authors:  Stanley A Plotkin
Journal:  Clin Vaccine Immunol       Date:  2010-05-12

Review 3.  Contributions of humoral and cellular immunity to vaccine-induced protection in humans.

Authors:  Ian J Amanna; Mark K Slifka
Journal:  Virology       Date:  2011-01-08       Impact factor: 3.616

Review 4.  Lessons from a modern review of the smallpox eradication files.

Authors:  Wolfram G Metzger; Carsten Köhler; Benjamin Mordmüller
Journal:  J R Soc Med       Date:  2015-10-02       Impact factor: 5.344

5.  Sex difference in immune response to vaccination: A participant-level meta-analysis of randomized trials of IMVAMUNE smallpox vaccine.

Authors:  Jesse D Troy; Heather R Hill; Marian G Ewell; Sharon E Frey
Journal:  Vaccine       Date:  2015-08-28       Impact factor: 3.641

6.  Persisting humoral antiviral immunity within the Japanese population after the discontinuation in 1976 of routine smallpox vaccinations.

Authors:  Shuji Hatakeyama; Kyoji Moriya; Masayuki Saijo; Yuji Morisawa; Ichiro Kurane; Kazuhiko Koike; Satoshi Kimura; Shigeru Morikawa
Journal:  Clin Diagn Lab Immunol       Date:  2005-04

7.  Protective immunity following vaccination: how is it defined?

Authors:  Ian J Amanna; Ilhem Messaoudi; Mark K Slifka
Journal:  Hum Vaccin       Date:  2008-02-19

8.  Impaired innate, humoral, and cellular immunity despite a take in smallpox vaccine recipients.

Authors:  Richard B Kennedy; Gregory A Poland; Inna G Ovsyannikova; Ann L Oberg; Yan W Asmann; Diane E Grill; Robert A Vierkant; Robert M Jacobson
Journal:  Vaccine       Date:  2016-05-11       Impact factor: 3.641

9.  Effect of vaccination with modified vaccinia Ankara (ACAM3000) on subsequent challenge with Dryvax.

Authors:  Michael S Seaman; Marissa B Wilck; Lindsey R Baden; Stephen R Walsh; Lauren E Grandpre; Colleen Devoy; Ayush Giri; Lizanne C Noble; Jane A Kleinjan; Kristen E Stevenson; Haesook T Kim; Raphael Dolin
Journal:  J Infect Dis       Date:  2010-05-01       Impact factor: 5.226

Review 10.  Smallpox vaccines for biodefense.

Authors:  Richard B Kennedy; Inna Ovsyannikova; Gregory A Poland
Journal:  Vaccine       Date:  2009-11-05       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.